154 related articles for article (PubMed ID: 32765089)
1. Patients of Myelodysplastic Syndrome with Mild/Moderate Myelofibrosis and a Monosomal Karyotype are Independently Associated with an Adverse Prognosis: Long-Term Follow-Up Data.
Wang N; Xu H; Li Q; Fang X; Liu J; Sui X; Zhang L; Jiang Y; Wang X
Cancer Manag Res; 2020; 12():5881-5891. PubMed ID: 32765089
[TBL] [Abstract][Full Text] [Related]
2. Monosomal karyotypes apart from complex karyotypes independently predict the outcome of myelodysplastic syndrome patients using a fluorescence in situ hybridization panel and conventional cytogenetics.
Wang N; Xu H; Li Q; Liu J; Sui X; Jiang Y; Fang X; Zhen C; Ding M; Yuan D; Zhang L; Wang X
Int J Lab Hematol; 2019 Aug; 41(4):519-529. PubMed ID: 31066997
[TBL] [Abstract][Full Text] [Related]
3. Monosomal karyotype of chromosome 5/7 was an independent poor prognostic factor for Chinese myelodysplastic syndrome patients.
Zhang T; Xu Y; Pan J; Qiu H; Wu D; Chen S; Sun A
Cancer Genet; 2016 Sep; 209(9):423-429. PubMed ID: 27423487
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of clinical features and prognosis of primary myelodysplastic syndromes with myelofibrosis patients].
Su T; Zhang PH; Xu ZF; Chen HS; Qin TJ; Zhang Y; Zhang HL; Fan LW; Pan LJ; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):378-82. PubMed ID: 22781796
[TBL] [Abstract][Full Text] [Related]
5. IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients.
Yang YT; Hou HA; Liu CY; Lin CC; Chou WC; Lee FY; Liu MC; Liu CW; Tang JL; Yao M; Li CC; Kuo YY; Huang SY; Ko BS; Chen CY; Hsu SC; Lin CT; Wu SJ; Tsay W; Chen YC; Tien HF
Am J Hematol; 2014 Sep; 89(9):E142-9. PubMed ID: 24845799
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.
Papageorgiou SG; Vasilatou D; Kontos CK; Kotsianidis I; Symeonidis A; Galanopoulos AG; Hatzimichael E; Megalakaki A; Poulakidas E; Diamantopoulos P; Vassilakopoulos TP; Zikos P; Papadaki H; Mparmparousi D; Bouronikou E; Panayiotidis P; Viniou NA; Pappa V
Am J Hematol; 2018 Jul; 93(7):895-901. PubMed ID: 29659040
[TBL] [Abstract][Full Text] [Related]
7. Moderate to Severe Marrow Fibrosis As a More Advanced Risk Factor for MDS and MDS-AML Patients With Excess of Blasts Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Wang J; Wang Q; Zhang H; He Y; Huang Y; Zhang R; Wei J; Ma Q; Pang A; Yang D; Chen X; Jiang E; Feng S; Zhai W; Han M
Transplant Cell Ther; 2021 Aug; 27(8):666.e1-666.e9. PubMed ID: 34020086
[TBL] [Abstract][Full Text] [Related]
8. [Clinical Significance of Monosomal Karyotype in MDS].
Guo SS; Gao PP; Mu QT; Ouyang GF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):860-866. PubMed ID: 31204945
[TBL] [Abstract][Full Text] [Related]
9. Monosomal karyotype improves IPSS-R stratification in MDS and AML patients treated with Azacitidine.
Cluzeau T; Mounier N; Karsenti JM; Richez V; Legros L; Gastaud L; Garnier G; Re D; Montagne N; Gutnecht J; Gabriel Fuzibet J; Auberger P; Raynaud S; Cassuto JP
Am J Hematol; 2013 Sep; 88(9):780-3. PubMed ID: 23757315
[TBL] [Abstract][Full Text] [Related]
10. Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome.
Ustun C; Trottier BJ; Sachs Z; DeFor TE; Shune L; Courville EL; Holtan SG; Dolan M; Weisdorf DJ; Warlick ED
Biol Blood Marrow Transplant; 2015 May; 21(5):866-72. PubMed ID: 25620751
[TBL] [Abstract][Full Text] [Related]
11. Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database.
Voso MT; Fenu S; Latagliata R; Buccisano F; Piciocchi A; Aloe-Spiriti MA; Breccia M; Criscuolo M; Andriani A; Mancini S; Niscola P; Naso V; Nobile C; Piccioni AL; D'Andrea M; D'Addosio A; Leone G; Venditti A
J Clin Oncol; 2013 Jul; 31(21):2671-7. PubMed ID: 23796988
[TBL] [Abstract][Full Text] [Related]
12. Monosomal and complex karyotypes as prognostic parameters in patients with International Prognostic Scoring System higher risk myelodysplastic syndrome treated with azacitidine.
Hwang KL; Song MK; Shin HJ; Na HJ; Shin DH; Kim JK; Moon JH; Ahn JS; Song IC; Hong J; Lee GW; Chung JS
Blood Res; 2014 Dec; 49(4):234-40. PubMed ID: 25548756
[TBL] [Abstract][Full Text] [Related]
13. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype.
Schwabkey ZI; Al Ali N; Chan O; Sallman DA; Padron E; Kuykendall AT; Talati C; Sweet K; Lancet JE; Komrokji RS
Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e52-e56. PubMed ID: 33093008
[TBL] [Abstract][Full Text] [Related]
15. Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes.
Buesche G; Teoman H; Wilczak W; Ganser A; Hecker H; Wilkens L; Göhring G; Schlegelberger B; Bock O; Georgii A; Kreipe H
Leukemia; 2008 Feb; 22(2):313-22. PubMed ID: 18033321
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome.
Zeng X; Xuan L; Fan Z; Zhang Y; Zhao K; Zhou Y; Xu J; Liu Q; Dai M
Exp Hematol Oncol; 2021 Aug; 10(1):44. PubMed ID: 34391477
[TBL] [Abstract][Full Text] [Related]
17. TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype.
Ren Y; Wang J; Zhang H; Mei C; Ye L; Luo Y; Zhou X; Zhu S; Jiang L; Wang L; Jin J; Tong H
Asia Pac J Clin Oncol; 2020 Jun; 16(3):172-179. PubMed ID: 32030889
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of monosomal karyotype in myelodysplastic syndrome: a meta-analysis.
Wu YC; Zhang XM; Zhu YD; Wu W
Hematology; 2019 Dec; 24(1):60-69. PubMed ID: 30129389
[TBL] [Abstract][Full Text] [Related]
19. Monosomal karyotype predicts inferior survival independently of a complex karyotype in patients with myelodysplastic syndromes.
McQuilten ZK; Sundararajan V; Andrianopoulos N; Curtis DJ; Wood EM; Campbell LJ; Wall M
Cancer; 2015 Sep; 121(17):2892-9. PubMed ID: 26043022
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromes.
Gangat N; Patnaik MM; Begna K; Kourelis T; Knudson RA; Ketterling RP; Hodnefield JM; Hanson CA; Pardanani A; Tefferi A
Am J Hematol; 2013 Aug; 88(8):690-3. PubMed ID: 23686868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
